Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis.
Şiran KeskeMerve AkyolCem TanrıöverBatu ÖzlüşenRüştü Emre AkcanUlaş GülerBilgin SaitBahar KaçmazMehmet GönenÖnder ErgönülPublished in: Infection (2023)
Among non-intubated severe COVID-19 cases, tocilizumab reduces the risk of invasive mechanical ventilation and mortality compared to standard-of-care treatment.
Keyphrases
- mechanical ventilation
- coronavirus disease
- sars cov
- rheumatoid arthritis
- acute respiratory distress syndrome
- intensive care unit
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- healthcare
- randomized controlled trial
- systematic review
- respiratory failure
- palliative care
- early onset
- cardiovascular events
- quality improvement
- extracorporeal membrane oxygenation
- risk factors
- respiratory syndrome coronavirus
- coronary artery disease
- drug induced
- health insurance
- chronic pain
- cardiovascular disease